Accelerating clinical development of idasanutlin through a physiologically-based pharmacokinetic modeling risk assessment for CYP450 isoenzyme related drug-drug interactions

2021 ◽  
pp. DMD-AR-2021-000720
Author(s):  
Kenichi Umehara ◽  
Yumi Cleary ◽  
Stephen Fowler ◽  
Neil Parrott ◽  
Dietrich W. Tuerck
Sign in / Sign up

Export Citation Format

Share Document